EP2501367
Formulation for HGH and RHIGF-1 combination
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.11.2010EP published:
21.1.2015EP application number:
10784450.8
EPO information:
European Patent Register
Max expiry date:
16.11.2030
Title:
Formulation for HGH and RHIGF-1 combination
Timeline
Today
17.11.2010EP application
21.1.2015EP Publication
Owner
Name:
IPSEN PHARMA S.A.S.Address:
65, Quai Georges Gorse, 92100, Boulogne-Billancourt, FR
Inventor
Name:
GOPINATH, EnonaAddress:
Redwood CityCalifornia, US
Name:
PARK, SusanAddress:
San FranciscoCalifornia, US
Name:
ARAKAWA, TsutomuAddress:
Thousand OaksCA, US
Name:
RICHARD, JoëlAddress:
Méré, FR
Name:
FAIS, FabioAddress:
Dreux, FR
Priority
Number:
261859 PDate:
17.11.2009Country:
US
Classification
Categories:
A61K 9/19, A61K 47/18, A61K 38/27, A61K 38/30